Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug - Oligonucleotide Therapeutics Society

Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug

OTS

Delivery,Reviews

July 5, 2020

SHARE

Post Views: 588

Debacker AJ, Voutila J, Catley M, Blakey D, Habib N.

Mol Ther. 2020 Jun 17:S1525-0016(20)30305-1.

Related articles

Subscribe to our Newsletter

Oligonucleotide Therapeutics Society

Oligonucleotide Therapeutics Society

c/o Event Innovations, Inc.
4377 Newport Avenue
San Diego, CA 92107, USA

(619) 795-9458
info@oligotherapeutics.org

Terms & Conditions

Resources

Stay Connected

Search

Subscribe in a reader

© Copyright 2012 – 2022 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Username/Email Address:
Password:
Forgot Password | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone:
Organization Name
Select Sectors

By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

Already have an account? Login

This website uses cookies and third party services. Ok